Study of Biochemical, Clinical and Hematological Profile of COVID-19 Patients in a Tertiary Care Hospital
Article Sidebar
Main Article Content
Abstract
Background: The clinical outcomes of patients vary based on age, gender, previous dengue infection, co-infections, biochemical/hematological parameters and comorbidities such as Hypertension, Diabetes and Pregnancy etc. Objectives: To evaluate the clinical outcomes of patients having COVID-19 along with their physical and biochemical parameters (Clinical Profile) Methods: A cross sectional study was carried on a total of 380 patients admitted in the various medical wards of Khyber Teaching Hospital/MTI, Peshawar from June 2020 to December 2020. IBM SPSS 26 and MS Excel were used for statistical analysis. Results: Fever, Headache, Cough, Sinusitis and Myalgia were the most common presenting complain whereas ARDS and Multiple organ failure were the major complications. DM, HTN and CAD were reported to be the major comorbidities in these patients. Biochemical markers such as Serum Ferritin, C-Reactive Protein and D-Dimers showed a wide range of deviation from the mean. Ferritin was 500.70±110.19 (ng/ml), D-Dimers were 450±103 (ng/ml) and C-Reactive Protein of 15.05±4.25 (mg/dl). Conclusion: COVID-19 is a global health issue and is becoming increasingly difficult to control and manage due to the high infectivity and airborne nature of the virus causing it. The menace of COVID-19 can only be dealt with proper public health awareness, mass campaign, media involvement, education of the masses and a sound clinical approach.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30185-9.
Lu R , Zhao X , Li J et al . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.
Chang D, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health care workers from subclinical coronavirus infection. Lancet Respir Med. 2020. https://doi.org/10.1016/S2213-2600(20)30066-7.
Stockman LJ , Bellamy R , Garner P . SARS: Systematic review of treatment effects . PLoS Med 2006 ; 3 : 1525 – 31.
Sheahan TP , Sims AC , Leist SR et al . Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV . Nat Commun 2020 ; 11 : 222
Holshue ML , DeBolt C , Lindquist S et al . First case of 2019 novel coronavirus in the United States . N Engl J Med 2020
National Health Commission of the People’s Republic of China. Diagnosis and Treatment of Pneumonia Caused by 2019-nCoV (version 6). 2020. http://www.gov.cn/zhengce/zhengceku/2020-02/19/content_5480948.htm.
WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. https://www.who.int/publicationsdetail/clinical-management-of-severe-acute-respiratory-infection-when-novelcoronavirus-(ncov)-infection-is-suspected.
Shanmugaraj B, Malla A, Phoolcharoen W. Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development. Pathogens. 2020;9(148)